Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00430846Phase 1Completed
Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies
Disease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin
Principalinvestigator
NCT00501735Phase 2Completed
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
Cutaneous T-cell Lymphoma (CTCL),
Principalinvestigator

Research Network

Collaboration Network

25 collaborators·65 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Washington University School of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dana Kennedy, PharmD

Seagen Inc.

Moderately Similar
3 trials

Shared therapeutic areas:

Lymphoma, Large-Cell, AnaplasticLymphoma, Non-HodgkinHodgkin Disease

Worked with same sponsors:

Seagen Inc.
Collaborated on 1 trial
Similarity Score34%

John Leonard, MD

Weill Medical College of Cornell University

Moderately Similar
1 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin

Worked with same sponsors:

Seagen Inc.
Collaborated on 1 trial
Similarity Score34%

Andres Forero, MD

University of Alabama at Birmingham

Moderately Similar
2 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin

Worked with same sponsors:

Seagen Inc.
Collaborated on 1 trial
Similarity Score34%

Anas Younes, MD

M.D. Anderson Cancer Center

Moderately Similar
4 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin

Worked with same sponsors:

Seagen Inc.
Collaborated on 1 trial
Similarity Score34%

Francine Foss, MD

Yale University

Related
6 trials

Shared therapeutic areas:

Lymphoma, T-Cell, CutaneousHodgkin Disease

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Gregory Reid, MSc, MBA

MethylGene Inc.

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score15%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score15%

Jun Mao, MD, MSCE

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score15%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score15%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin

Worked with same sponsors:

BioCryst Pharmaceuticals
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00430846Phase 1PrincipalInvestigator

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

Disease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin
Completed
NCT00501735Phase 2PrincipalInvestigator

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

Cutaneous T-cell Lymphoma (CTCL),
Completed

All 2 trials loaded